Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Nimotuzumab |
| Trade Name | |
| Synonyms | Theraloc|hR3 |
| Drug Descriptions |
Nimotuzumab is a humanized anti-EGFR antibody that blocks EGFR signaling, resulting in anti-tumor activity (PMID: 25842083, PMID: 32588692, PMID: 32021306). |
| DrugClasses | EGFR Antibody 72 |
| CAS Registry Number | 828933-51-3 |
| NCIT ID | C2733 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Afatinib + Nimotuzumab | Afatinib Nimotuzumab | 0 | 0 |
| Cisplatin + Irinotecan + Nimotuzumab | Cisplatin Irinotecan Nimotuzumab | 0 | 0 |
| Erlotinib + Nimotuzumab | Erlotinib Nimotuzumab | 0 | 0 |
| Gemcitabine + Nimotuzumab | Gemcitabine Nimotuzumab | 0 | 0 |
| Irinotecan + Nimotuzumab | Irinotecan Nimotuzumab | 0 | 0 |
| Nimotuzumab | Nimotuzumab | 0 | 0 |
| Nimotuzumab + Nivolumab | Nimotuzumab Nivolumab | 0 | 1 |
| Nimotuzumab + Vinorelbine | Nimotuzumab Vinorelbine | 0 | 1 |